Product Information
CLONAZEPAM 2 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0378 per EA under NDC 16729013800. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729013800
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077147On Market Since
6/3/2011
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0378 per EA |
|---|---|
| All-time high | $0.0478 (Apr 15, 2020) |
| All-time low | $0.0316 (Nov 20, 2024) |
| 52-week high | $0.0436 |
| 52-week low | $0.0378 |
| Median price | $0.0380 |
| Average price | $0.0385 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0378 per EA (NDC 16729013800), effective Jun 24, 2026.
How has the price of CLONAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG TABLET has declined 3.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG TABLET?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 2 MG TABLET has ranged from a low of $0.0316 (Nov 20, 2024) to a high of $0.0478 (Apr 15, 2020), with a median of $0.0380 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 2 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 2 MG TABLET?
CLONAZEPAM 2 MG TABLET (NDC 16729013800) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification